Objective: To investigate the diagnostic value and prognostic value of HPV and P16 protein in patients with HSIL and to provide a reference for the clinical diagnosis and assessment of the prognosis of patients with H...Objective: To investigate the diagnostic value and prognostic value of HPV and P16 protein in patients with HSIL and to provide a reference for the clinical diagnosis and assessment of the prognosis of patients with HSIL. Methods: The surgical treatment of HSIL patients from January 2013 to January 2015 in our hospital were selected. All patients were routinely tested for HPV and P16 protein, All patients were followed up for 1 year. Patients were divided into progressive group and quiescent group according to whether the disease progressed one year after surgery. Preoperative HPV and P16 protein levels were compared between the two groups. Using receiver operating curve (ROC curve) Analysis of HPV diagnostic value of HSIL. The levels of HPV and P16 protein in the two groups were analyzed and compared. Results: The quantitative level of high-risk HPV-DNA after LEEP was significantly lower than that before operation. The level of P16 protein in preoperative patients was higher than that before operation, and the difference was statistically significant. There were 21 patients in the postoperative progression group, and the average HPV-DNA content in the patients in the progression group was higher than that in the control group within one year after operation. The difference was statistically significant. The P16 protein level in patients in advanced group was significantly higher than that in resting group. Preoperative HPV-DNA levels and P16 protein levels in patients with progressive disease were significantly higher than those in still group. ROC curve analysis showed that the cut-off value of 2.441, HPV-DNA prediction of HSIL patients one year after the recurrence of the sensitivity was 95.12%, the specificity was 76.16%, under the curve area of 0.878;7.4 cut-off value, P16 The predictive value of HSIL patients recurrence after 1 year was 71.95%, specificity was 66.67%, and the area under the curve was 0.753. The recurrence group HPV-DNA content and P16 protein level showed a significant positive correlation, with statistical significance. Conclusions: LEEP can reduce the postoperative levels of HPV and P16 protein in patients with HSIL. The HPV and P16 protein levels are of high value for the early diagnosis of HSIL and the prediction of postoperative disease progression.展开更多
目的探讨宫颈癌(cervical cancer)及其癌前病变组织中p16蛋白表达及其与人乳头瘤病毒(human papillomavirus,HPV)感染的关系。方法采用免疫组化(immunohistochemistry,IHC)SP法检测40例宫颈浸润癌(invasive carcinoma of cervix,ICC)标...目的探讨宫颈癌(cervical cancer)及其癌前病变组织中p16蛋白表达及其与人乳头瘤病毒(human papillomavirus,HPV)感染的关系。方法采用免疫组化(immunohistochemistry,IHC)SP法检测40例宫颈浸润癌(invasive carcinoma of cervix,ICC)标本(ICC组)、20例低度宫颈上皮内瘤样病变(cervical intraepithelial neoplasiaⅠ,CINⅠ)标本(CINⅠ组)、30例高度宫颈上皮内瘤样病变(CINⅡ~Ⅲ)(CINⅡ~Ⅲ组)标本和20例正常宫颈组织标本(对照组)的p16蛋白表达;用导流杂交基因芯片技术(HybriMax)测定上述标本的人乳头瘤病毒分型。结果P16蛋白在正常宫颈上皮(对照组)无表达,在宫颈癌及癌前病变组织呈现过表达(ICC组,CINⅠ组,CINⅡ~Ⅲ组);在CINⅠ,CINIⅠ~Ⅲ,ICC组过表达率分别为35.0%,83.3%和100.0%。P16蛋白表达随宫颈病变级别进展而增加(P<0.001)。高危人乳头状瘤病毒在正常宫颈上皮(对照组)的感染率为0,CINⅠ,CINⅡ~Ⅲ,ICC组分别为55.0%,80.0%和92.5%。HPV-16和(或)-18亚型是宫颈癌及癌前病变最常见感染亚型。P16蛋白过表达在高危型人乳头瘤病毒(high-risk human papillomavirus,HR-HPV)感染宫颈组织明显高于HPV呈阴性或低危型人乳头瘤病毒(low-risk human papillomavirus,LR-HPV)感染宫颈组织(P<0.05)。结论P16蛋白过表达,可用于区分正常宫颈和宫颈癌前病变及宫颈浸润癌组织。P16蛋白过表达与高危型人乳头瘤病毒感染有关。展开更多
基金Hainan Natural Science Foundation Surface Project(20168279).
文摘Objective: To investigate the diagnostic value and prognostic value of HPV and P16 protein in patients with HSIL and to provide a reference for the clinical diagnosis and assessment of the prognosis of patients with HSIL. Methods: The surgical treatment of HSIL patients from January 2013 to January 2015 in our hospital were selected. All patients were routinely tested for HPV and P16 protein, All patients were followed up for 1 year. Patients were divided into progressive group and quiescent group according to whether the disease progressed one year after surgery. Preoperative HPV and P16 protein levels were compared between the two groups. Using receiver operating curve (ROC curve) Analysis of HPV diagnostic value of HSIL. The levels of HPV and P16 protein in the two groups were analyzed and compared. Results: The quantitative level of high-risk HPV-DNA after LEEP was significantly lower than that before operation. The level of P16 protein in preoperative patients was higher than that before operation, and the difference was statistically significant. There were 21 patients in the postoperative progression group, and the average HPV-DNA content in the patients in the progression group was higher than that in the control group within one year after operation. The difference was statistically significant. The P16 protein level in patients in advanced group was significantly higher than that in resting group. Preoperative HPV-DNA levels and P16 protein levels in patients with progressive disease were significantly higher than those in still group. ROC curve analysis showed that the cut-off value of 2.441, HPV-DNA prediction of HSIL patients one year after the recurrence of the sensitivity was 95.12%, the specificity was 76.16%, under the curve area of 0.878;7.4 cut-off value, P16 The predictive value of HSIL patients recurrence after 1 year was 71.95%, specificity was 66.67%, and the area under the curve was 0.753. The recurrence group HPV-DNA content and P16 protein level showed a significant positive correlation, with statistical significance. Conclusions: LEEP can reduce the postoperative levels of HPV and P16 protein in patients with HSIL. The HPV and P16 protein levels are of high value for the early diagnosis of HSIL and the prediction of postoperative disease progression.
文摘目的探讨宫颈癌(cervical cancer)及其癌前病变组织中p16蛋白表达及其与人乳头瘤病毒(human papillomavirus,HPV)感染的关系。方法采用免疫组化(immunohistochemistry,IHC)SP法检测40例宫颈浸润癌(invasive carcinoma of cervix,ICC)标本(ICC组)、20例低度宫颈上皮内瘤样病变(cervical intraepithelial neoplasiaⅠ,CINⅠ)标本(CINⅠ组)、30例高度宫颈上皮内瘤样病变(CINⅡ~Ⅲ)(CINⅡ~Ⅲ组)标本和20例正常宫颈组织标本(对照组)的p16蛋白表达;用导流杂交基因芯片技术(HybriMax)测定上述标本的人乳头瘤病毒分型。结果P16蛋白在正常宫颈上皮(对照组)无表达,在宫颈癌及癌前病变组织呈现过表达(ICC组,CINⅠ组,CINⅡ~Ⅲ组);在CINⅠ,CINIⅠ~Ⅲ,ICC组过表达率分别为35.0%,83.3%和100.0%。P16蛋白表达随宫颈病变级别进展而增加(P<0.001)。高危人乳头状瘤病毒在正常宫颈上皮(对照组)的感染率为0,CINⅠ,CINⅡ~Ⅲ,ICC组分别为55.0%,80.0%和92.5%。HPV-16和(或)-18亚型是宫颈癌及癌前病变最常见感染亚型。P16蛋白过表达在高危型人乳头瘤病毒(high-risk human papillomavirus,HR-HPV)感染宫颈组织明显高于HPV呈阴性或低危型人乳头瘤病毒(low-risk human papillomavirus,LR-HPV)感染宫颈组织(P<0.05)。结论P16蛋白过表达,可用于区分正常宫颈和宫颈癌前病变及宫颈浸润癌组织。P16蛋白过表达与高危型人乳头瘤病毒感染有关。